相关实验视频

Updated: Jun 1, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

探索TROP2基因沉默在肝细胞癌中的治疗潜力

Fatma Yakoub¹, Hanem Hassan², Samah Mamdouh²

¹Specialist, Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt.

Recent patents on biotechnology

|January 21, 2025

概括

在肝细胞癌 (HCC) 细胞中用siRNA向热囊细胞表面抗原2 (Trop2) 减少了瘤生长和迁移. 这种下调还增加了细胞亡和受影响的基因表达,表明Trop2是HCC的有希望的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

热囊细胞表面抗原2 (Trop2) 是一种与癌症进展和转移相关的跨膜糖蛋白.
肝细胞癌 (HCC) 是一个重要的全球健康问题,Trop2与其发展有关.
准Trop2为包括HCC在内的各种癌症提供了潜在的治疗策略.

研究的目的:

研究Trop2敲击对HepG2肝癌细胞的表型和分子特征的影响.
评估小干扰RNA (siRNA) 在降低HCC细胞Trop2表达中的有效性.
评估Trop2下调对癌细胞行为和基因表达的影响.

主要方法:

在不同的时间间隔 (6,24,48小时) 中,HepG2细胞被感染了Trop2向siRNA (3nM,5nM,7nM) 的不同度.
使用实时PCR量化Trop2 mRNA表达.
分析了亡,迁移,形态学,组织病理学特征和TPM1基因表达.

主要成果:

在siRNA转染后,Trop2 mRNA水平以时间和度依赖的方式显著下降.
Trop2的淘汰导致了亡的增加和细胞迁移的减少.
观察到细胞形态和细胞病理特征的变化,并对TPM1基因表达的上调调节.

结论:

通过siRNA降低Trop2的调节有效调节肝细胞癌细胞特征.
这些发现强调了Trop2作为HCC管理的可行的治疗目标的潜力.
根据这些有前途的结果,对Trop2向治疗HCC的进一步研究是有必要的.

关键词:

肝细胞癌肝细胞癌在TPM1中,我们可以使用TPM1.热带地区热带地区敲击下来. 这是一次敲击.siRNA 是一个RNA.

更多相关视频

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

Published on: October 24, 2016

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

相关概念视频

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...